# Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

> **NCT02315755** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 102 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02315755
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-11
- **Primary completion:** 2017-11-20
- **Final completion:** 2017-11-20
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02315755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02315755, "Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02315755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*